ZYVERSA THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Jul 25 · Aug 25 · Sep 25)
Total Assets
$348K
↓-98.3% -$20Mvs FY2024
Total Liabilities
$13M
↑+13.4% +$2Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $348K | $21M |
| Current Assets | $348K | $2M |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $348K | $2M |
| Non-Current Assets | $0 | $19M |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $0 | $19M |
| Total Liab+Eq | $348K | $21M |
| Current Liab. | $13M | $11M |
| Accounts Payable | $10M | $9M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $3M | $2M |
| Non-Current Liab. | $0 | $852K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $852K |
| Equity | $-12M | $9M |
| Retained Earnings | $138M | $113M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · ZVSA · Comparing FY2025 vs FY2024